We are pleased to announce the approval of non-exclusive listing agreements with
In summary, this will result in LifeHealthcare and
DHBs will be able to continue to purchase other suppliers' brands of Orthopaedic Products as the agreements are not for sole supply.
Any changes to the original proposal
This decision was subject to the following consultation letters
No changes have been made to either agreement as a result of consultation.
Who we think will be most interested
Suppliers and Wholesalers
Detail about this decision
In
After evaluating LifeHealthcare's and Surgical Innovation's proposals and consulting on the provisional agreements reached with them, PHARMAC has decided to list LifeHealthcare's and Surgical Innovation's ranges of Orthopaedic Products in Part III of Section H of the Pharmaceutical Schedule from
These two agreements are the final agreements that will be entered into in the orthopaedic products category as a result of the RFP.
Our response to what you told us
We appreciate the time people took to respond to this consultation.
All consultation responses received by
Contact:
Tel: 021 863 342
Email: media@pharmac.govt.nz
(C) 2020 Electronic News Publishing, source